Search Results 1571-1580 of 15337 for Hepatitis b

1. Transplant Medicine Physicians - Medical Professionals - Mayo Clinic

   ... Hepatitis C, Hepatitis B, Hepatocellular carcinoma, Primary biliary cholangitis, Nonalcoholic fatty liver disease, Cirrhosis, Acute liver failure ...

2. A Study To Evaluate The Safety And Efficacy Of ABT-494 For Induction And Maintenance Therapy In Subjects With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

   ... hepatitis B core antibody (HBc Ab) positive (+) subjects (and for Hepatitis B surface antibody positive (+) subjects where mandated by local requirements); ...

3. Abiraterone/Prednisone, Olaparib, Or Abiraterone/Prednisone + Olaparib In Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects - Mayo Clinic

   Patients with known active Hepatitis B or Hepatitis C. Patients with baseline moderate to severe hepatic impairment (Child-Pugh Class B and C). Persistent ...

4. Publications - Fahma O. Mohamed - Mayo Clinic

   A Strategy to Improve Hepatitis B Vaccine Uptake in Hesitant Adults: The Offer-Offer-Test-Vaccinate Approach. J Prim Care Community Health. 2025 Jan-Dec; 16: ...

5. A Study To Evaluate Effectiveness And Safety Of Lenzilumab In Hospitalized Patients With COVID-19 Pneumonia (Enrolling By Invitation Only) - Mayo Clinic

   Known history of hepatitis A, hepatitis B, hepatitis C or HIV infection. History of pulmonary alveolar proteinosis (PAP). Requiring invasive mechanical ...

6. A Study To Evaluate The Safety And Effectiveness Of The Drug TTP399 To Target A1c In Type 2 Diabetics - Mayo Clinic

   Presence of chronic active hepatitis (hepatitis B, hepatitis C, nonalcoholic steatohepatitis [NASH]) and/or known liver cirrhosis. Participation in any ...

7. Primary biliary cholangitis (PBC) - Symptoms and causes - Mayo Clinic

   Primary biliary cholangitis is a type of liver disease that damages the bile ducts. Early recognition and treatment may help prevent complications.

8. Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence - Mayo Clinic

   ... B/C/D, or Stage IV cutaneous melanoma who are at high risk for recurrence ... Any positive test result for hepatitis B virus or hepatitis C virus ...

9. Study Of AG-120 In Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy) - Mayo Clinic

   Have known active hepatitis B (HBV) or hepatitis C (HCV) infections, known positive human immunodeficiency virus (HIV) antibody results, or acquired ...

10. A Study Of New Outcome Measures To Assess The Progression Of Amyotrophic Lateral Sclerosis - Mayo Clinic

    History of or a positive test result at screening for hepatitis C virus (HCV) antibody or hepatitis B virus (HBV); Possibility of neuromuscular weakness ...